[Therapy of recurrent herpes simplex].
The topical and systemic possibilities of treatment of herpes simplex recidivans are discussed in a brief report. The antigen therapy with Lupidon is mentioned in detail. A selection of important clinical reports on Lupidon is commented. These reports demonstrate a good to very good therapeutic effect of Lupidon in relapsing herpes simplex with more than 1500 controlled patients. A statistically confirmed result of the long-term antigen therapy with Lupidon was particularly demonstrated in controlled double blank tests. Up to now there were not observed any severe side effects with this great number of patients.
D000914:Antibodies, Viral; D000917:Antibody Formation; D005069:Evaluation Studies as Topic; D006561:Herpes Simplex / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D012008:Recurrence; D018139:Simplexvirus / Q000276:immunology
D000914:Antibodies, Viral
Therapie von Herpes simplex rezidivans